Elexacaftor-d3

• CAT Number: S000044
• Molecular Formula: C26H31D3F3N7O4S
• Molecular Weight: 600.67
• Purity: ≥95%
• IUPAC Name: N-[3-methyl-1-(trideuteriomethyl)pyrazol-4-yl]sulfonyl-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide
• InChI: InChI=1S/C26H34F3N7O4S/c1-16-12-25(5,6)35(13-16)22-18(23(37)33-41(38,39)19-14-34(7)31-17(19)2)8-9-20(30-22)36-11-10-21(32-36)40-15-24(3,4)26(27,28)29/h8-11,14,16H,12-13,15H2,1-7H3,(H,33,37)/t16-/m0/s1/i7D3
• InChIKey: MVRHVFSOIWFBTE-JBFRPYDWSA-N
• SMILES: [2H]C([2H])([2H])N1C=C(C(=N1)C)S(=O)(=O)NC(=O)C2=C(N=C(C=C2)N3C=CC(=N3)OCC(C)(C)C(F)(F)F)N4C[C@H](CC4(C)C)C

Elexacaftor-d3 is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Elexacaftor is essential for studies involving cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmacokinetics, and metabolic pathways. Featuring three deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for respiratory disease research and drug development, Elexacaftor-d3 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.